Oouch again...another one?DIAGNOS Inc. July 22, 2016 15:11 ET DIAGNOS Announces Private Placement BROSSARD, QUEBEC--(Marketwired - July 22, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces that it has completed a private placement ("Private Placement") of 19 units (each a "Unit") for gross cash proceeds of $190,000. Each Unit consists of: One Secured Convertible Debenture ("Debenture"), $10,000 principal amount, 1-Year Term, 12% Annual Interest, and 50,000 Stock Warrants (each a "Warrant') entitling the holder to purchase one Common Share ("Share") per Warrant at a price of $0.06 per Share for a period of one year from the date of issuance. At the sole option of the holder of the Debentures, the principal amount of the Debentures may be converted at any time during the term, in whole or in part, into common shares of the Corporation at a price of $0.06 per common share. Any accrued interest on the principal, at time of conversion, is immediately payable in cash. Cash proceeds will be used to fund the Corporation's operating expenses. The Corporation retained the services of Leede Jones Gable ("LJG"), to act as a referral agent in connection with the Private Placement. As per the terms of the engagement agreement, LJG is entitled to a commission in cash of $4,750. The Debentures are sold in Canada on a prospectus-exempt basis and the Shares underlying the Debentures and Warrants are subject to a statutory four-month hold period from the closing date. This Private Placement is subject to receipt of all required regulatory approvals, including the approval of the TSX Venture Exchange, as well as the execution of formal documentation. All monies quoted in this press release shall be stated and paid in lawful money of Canada.